Parkinson's disease and cardiovascular involvement: Edifying insights (Review)

Area of Science:

• Neurology
• Cardiology
• Pharmacology

Background:

• Parkinson's disease (PD) is a common neurodegenerative disorder with significant impacts on patient quality of life, morbidity, and survival.
• Cardiovascular diseases (CVDs) are a leading cause of mortality globally and frequently co-exist with PD.
• Cardiac dysautonomia, including hypotension and hypertension, is a prevalent cardiovascular manifestation in PD patients.

Purpose of the Study:

• To provide a comprehensive review of current data on overlapping cardiovascular diseases in patients with Parkinson's disease.
• To explore the mechanisms underlying cardiovascular manifestations in PD.
• To examine the cardiovascular adverse reactions associated with PD medications.

Main Methods:

• Literature review of existing studies on cardiovascular disease in Parkinson's disease.
• Analysis of data on cardiac dysautonomia, ischemic heart disease, heart failure, and arrhythmias in PD patients.
• Review of research on the cardiovascular side effects of PD medications like levodopa and dopamine agonists.

Main Results:

• Cardiac dysautonomia is a common cardiovascular issue in PD patients.
• PD patients have an elevated risk for ischemic heart disease, heart failure, and arrhythmias.
• Medications used to treat PD can lead to adverse cardiovascular events, though mechanisms require further study.

Conclusions:

• There is a significant overlap between Parkinson's disease and cardiovascular diseases.
• Understanding the interplay between PD, its treatments, and cardiovascular health is crucial for patient management.
• Further research is needed to elucidate the mechanisms linking PD and CVDs and to mitigate medication-related adverse effects.